The purpose of this study was to identify the trends, frequency, and nature of industry sponsorship of plastic surgery research since the establishment of conflicts of interest (COI) reporting policies.
RESULTS:
A total of 3722 articles met the inclusion criteria and were included in the analysis. The incidence of COI steadily decreased from 24% in 2009 to 9% in 2013. The types of COI also significantly changed from 2008 to 2013 (p < 0.001). In 2008, 71% and 17% of COI were categorized as research support and consultant/employee, respectively. However by 2013, 34% and 57% were categorized as research support and consultant/employee, respectively. A multivariate regression analysis revealed that article subspecialty topic was associated with disclosure COI (p < 0.0001).
CONCLUSION:
If self-reporting of COI are assumed to be accurate, the number of surgeon-reported COI in plastic surgery declined overall. Our analysis also suggests that industry has steadily increased the number of consultancies rather than direct research support over this period. 
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WALKING ON SUNSHINE: CONTINUED SURVEILLANCE OF INDUSTRY'S PAYMENTS TO PLASTIC SURGEONS
PURPOSE:
The Physician Payment Sunshine Act (PPSA) is a government initiative requiring all biomedical companies to publicly disclose payments to physicians. There continues to be misinterpretation and a lack of awareness amongst plastic surgeons, the public, and the media regarding these financial transactions. The goal of this study is to evaluate changes in the PPSA data since its implementation in 2014.
METHODS:
Using PPSA data (Jan 2014-Dec 2015), we studied and compared the distribution of non-research industry payments made to plastic surgeons nationally.
RESULTS:
During the 2015 and 2014 fiscal years, industry paid $28,876,097 and $22,215,693, respectively, to ~6,500 plastic surgeons. In both fiscal years, ~25% of all plastic surgeons received <$100, ~50% between $100 and $999, ~15% between $1,000 and $9,999, 3.1% between $10,000-$99,999, and 0.4% in excess of $100,000. The four largest payment categories were: royalty or licensing fees ($7,626,632 
CONCLUSION:
During 2014-2015, ~75% of plastic surgeons received industry payments of <$1,000. The largest payment category was royalty and licensing fees, paid to <0.005%. Over the two-year period, our analysis revealed changes in payments amounts and types. Awareness and continued surveillance of the PPSA data are critical to better understand industry payments to plastic surgeons. 
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THE SAFETY OF PREOPERATIVE VERSUS POSTOPERATIVE ENOXAPARIN CHEMOPROPHYLAXIS IN AUTOLOGOUS
